TABLE IV.
The differences between final accumulated doses using morfeus and Hybrid methods. In DSC and surface distance difference, values in brackets show the worst and the best performance cases of the Hybrid compared to morfeus, respectively.
| Patient No. | DHI | % of DIR-mapped GTV volume difference (morfeus–Hybrid) | Surface distance difference (mm) (morfeus–Hybrid) | Dice difference (morfeus–Hybrid) | Dmin difference (Gy) (morfeus–Hybrid) |
|---|---|---|---|---|---|
| 1 | 14.2 | 28.4 ± 10.0 (11.1,37.6) | −0.4 ± 0.3 (−0.5,0.7) | 0.05 ± −0.01 (0.12,−0.05) | 0.0 |
| 2 | 17.4 | 23.8 ± 4.0 (16.8,27.1) | 2.1 ± 0.9 (1.0,5.2) | −0.08 ± 0.04 (0.01,−0.17) | 2.1 |
| 3 | 27.5 | 20.1 ± 4.1 (15.2,25.1) | 3.9 ± −0.1 (2.9,6.5) | −0.09 ± 0.01 (−0.06,−0.11) | 2.5 |
| 4 | 13.0 | 26.5 ± 14.6 (5.0,41.7) | 1.2 ± 0.5 (0.9,4.5) | −0.13 ± 0.06 (0.07,−0.36) | 0.3 |
| 5 | 10.6 | 6.4 ± 4.2 (1.0,14.6) | 1.3 ± 0.6 (0.5,3.2) | −0.14 ± 0.09 (−0.01,−0.29) | 0.2 |
| 6 | 19.9 | 14.1 ± 8.1 (0.0,26.0) | 2.4 ± 0.3 (2.6,5.0) | −0.18 ± 0.03 (−0.06,−0.27) | 0.1 |
| 7 | 21.4 | 9.5 ± 4.2 (4.7,14.3) | 1.9 ± 0.2 (2.3,4.0) | −0.08 ± 0.00 (−0.02,−0.14) | 2.2 |
| 8 | 18.5 | 4.6 ± 4.5 (0.5,13.2) | 0.5 ± 0.9 (−0.7,2.6) | −0.05 ± 0.06 (0.01,−0.11) | 0.5 |
| 9,1 | 19.6 | 11.8 ± 9.7 (0.8,30.8) | 0.8 ± 0.1 (0.7,1.7) | −0.13 ± 0.06 (0.01,−0.33) | 0.5 |
| 9,2 | 16.7 | 2.1 ± 1.2 (0.3,3.8) | 0.1 ± 0.1 (−0.4,4.7) | −0.01 ± 0.00 (0.10,−0.19) | 0.4 |
| 10,1 | 23.3 | 25.4 ± 6.4 (15.2,33.1) | 0.4 ± 0.4 (0.1,1.7) | −0.20 ± 0.08 (0.01,−0.40) | 0.2 |
| 10,2 | 11.8 | 15.2 ± 9.3 (2.4,31.7) | 1.2 ± 0.2 (0.9,4.4) | −0.02 ± 0.03 (0.02,−0.10) | 0.3 |
| Average | 17.8 | 28.4 ± 10.0 (11.1,37.6) | 1.3 ± 0.4 (0.8,3.7) | −0.1 ± −0.04 (0.01, −0.24) | 0.8 |